Skip to main content
MyCapitol LogoMyCapitol

S 5510 · 118th Congress

Open Payments Expansion Act

This bill requires drug and medical device manufacturers to publicly report any money they give to patient advocacy organizations. Starting in March 2026, and then every year after that, these companies must disclose the name of each patient advocacy group they funded and how much money they gave them. This applies…

Sponsor
Grassley, Chuck (R-IA)
Introduced
2024-12-12
Policy area
Social Welfare
Latest action
Read twice and referred to the Committee on Finance.

Digging through Congress... 🔍